Works matching IS 10837159 AND DT 2016 AND VI 21 AND IP 4
Results: 18
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 418, doi. 10.1634/theoncologist.2015-0321
- By:
- Publication type:
- Article
Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 508, doi. 10.1634/theoncologist.2015-0377
- By:
- Publication type:
- Article
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering--A Cross-Sectional Analysis.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 487, doi. 10.1634/theoncologist.2015-0397
- By:
- Publication type:
- Article
Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 393, doi. 10.1634/theoncologist.2015-0477
- By:
- Publication type:
- Article
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 404, doi. 10.1634/theoncologist.2015-0351
- By:
- Publication type:
- Article
The Other Side of Bad News.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 506, doi. 10.1634/theoncologist.2015-0487
- By:
- Publication type:
- Article
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 402, doi. 10.1634/theoncologist.2015-0467
- By:
- Publication type:
- Article
Smoking Cessation Support Among Oncology Practitioners in a Regional Cancer Center in the Middle East--Improving a Critical Service for Cancer Care.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 503, doi. 10.1634/theoncologist.2015-0305
- By:
- Publication type:
- Article
Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 467, doi. 10.1634/theoncologist.2015-0481
- By:
- Publication type:
- Article
Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 475, doi. 10.1634/theoncologist.2015-0380
- By:
- Publication type:
- Article
The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 453, doi. 10.1634/theoncologist.2015-0075
- By:
- Publication type:
- Article
The Log Odds of Positive Lymph Nodes Stratifies and Predicts Survival of High-Risk Individuals Among Stage III Rectal Cancer Patients.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 425, doi. 10.1634/theoncologist.2015-0441
- By:
- Publication type:
- Article
Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 461, doi. 10.1634/theoncologist.2015-0473
- By:
- Publication type:
- Article
Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen:What Have We Learned?
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 514, doi. 10.1634/theoncologist.2015-0267
- By:
- Publication type:
- Article
Candidate Predictors of Health-Related Quality of Life of Colorectal Cancer Survivors: A Systematic Review.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 433, doi. 10.1634/theoncologist.2015-0258
- By:
- Publication type:
- Article
MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 481, doi. 10.1634/theoncologist.2015-0510
- By:
- Publication type:
- Article
Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 494, doi. 10.1634/theoncologist.2015-0301
- By:
- Publication type:
- Article